Aluminum Alloy 8011
Dingang
| Aluminum Alloy: | |
|---|---|
| Aluminum Foil Thickness: | |
| Color Options::: | |
| ID: | |
| Temper: | |
| Availability: | |
| Quantity: | |
Medical-standard lacquered aluminum foil is designed as pharmaceutical blister lidding for moisture-sensitive hard capsules, selected HPMC capsules and compatible solid oral dosage forms requiring high barrier protection and controlled push-through opening.
The current product specification uses 8011-H18 hard-temper aluminum foil in a typical thickness range of 20–25μm. A printable or protective outer primer and a pharmaceutical heat-seal lacquer are applied according to the blister forming web and packaging-line requirements.
For moisture-sensitive formulations, final package performance depends on the complete blister system, including aluminum lidding foil, PVC, PVC/PVdC, high-barrier polymer or cold-form forming web, seal integrity, cavity geometry and validated storage conditions.
Request a Pharmaceutical Foil Quotation
Technical Property | Published / Available Specification | Purchasing Consideration |
|---|---|---|
Product Type | Pharmaceutical push-through blister lidding foil | For compatible capsules, tablets and moisture-sensitive solid dosage forms |
Primary Alloy | AA8011 | Confirm applicable aluminum specification and certificate requirement |
Temper | H18 hard temper | Provides controlled push-through characteristics for conventional blister lidding |
Foil Thickness | 20–25μm | Select according to capsule strength, blister cavity and required push-through force |
Published Gauge Tolerance | ±3% | Confirm thickness measurement and sampling method before contractual use |
Coating Structure | Print/protective primer / 8011-H18 aluminum / heat-seal lacquer | Primer and HSL chemistry should match printing and forming-web requirements |
Published WVTR Reference | <0.01g/m²·24h | Confirm test method, temperature, RH and whether value applies to flat material or complete construction |
Published Seal Strength | ≥7.5N/15mm to PVC/PVdC reference | Confirm forming web, seal temperature, pressure, dwell time and peel-test method |
Forming-Web Compatibility | PVC / PVC-PVdC / compatible cold-form or other approved structures | Heat-seal lacquer must be matched to the actual sealing surface |
Printing | Printable exterior primer available | Specify ink system, number of colors, artwork, codes and heat exposure |
Pinhole Requirement | Project-specific | Define inspection method and maximum acceptable defects rather than assuming zero pinholes |
Residual Solvent | To be controlled according to coating and printing specification | Specify test method and maximum permitted residual-solvent value where required |
Roll Width | Custom slitting according to packaging line | Specify width tolerance, slit-edge quality and winding direction |
Documentation References | SFDA / SASO / FDA DMF / ISO 15378 / GMP references currently published | Request current documents applicable to the manufacturing site, material construction and destination market |
Published barrier and sealing values should be linked to defined laboratory methods and material constructions. Pharmaceutical packaging qualification should use agreed test methods and acceptance criteria for the actual blister system.
Request Technical Data & Samples
Capsules and hygroscopic pharmaceutical formulations can be sensitive to environmental humidity. Excess moisture or moisture loss can affect the capsule shell, formulation stability, handling characteristics or product performance.
Hard gelatin capsules contain their own equilibrium moisture and can become brittle if excessive moisture is removed from the shell. Hygroscopic formulations inside the capsule can increase this risk by absorbing moisture from the capsule shell.
For this reason, packaging selection should be based on the moisture sensitivity of both the capsule shell and the encapsulated formulation rather than assuming that the highest possible external moisture barrier is always the only design criterion.
8011-H18 is commonly used for pharmaceutical push-through lidding because the hard temper provides controlled rupture behavior when pressure is applied through the blister cavity.
Unlike soft-temper foil designed for forming, H18 lidding is intended to fracture rather than undergo extensive plastic deformation during conventional push-through opening.
The lidding foil should provide sufficient strength for production, sealing, handling and distribution while still allowing the patient to open the blister without excessive force that could damage a fragile capsule shell.
Push-through performance should therefore be evaluated with the actual capsule, blister cavity and forming web rather than by foil thickness alone.
Selection Factor | 20μm | 25μm |
|---|---|---|
Foil Mass | Lower | Higher |
Burst / Push-Through Force | Generally lower under comparable conditions | Generally higher under comparable conditions |
Fragile Hard Capsules | Can provide easier push-through where validated | Should be evaluated for risk of capsule compression during opening |
Seal Performance | Primarily determined by HSL and sealing conditions | Primarily determined by HSL and sealing conditions |
Final Selection | Validate with actual blister and capsule | Validate with actual blister and capsule |
A continuous aluminum foil layer provides extremely high resistance to water-vapor transmission through the intact metallic layer.
The current product information lists a WVTR reference of <0.01g/m²·24h. Where this value is required contractually, the buyer should specify or confirm the applicable test method, temperature, relative humidity and sample construction.
The moisture barrier of a finished blister pack should not be calculated from lidding foil alone. The forming web, cavity geometry, seal width, package edges and storage environment can significantly influence the moisture reaching the dosage form.
Forming-Web Direction | General Barrier Consideration | Lidding Requirement |
|---|---|---|
PVC | Common thermoform blister substrate; overall moisture barrier may be insufficient for highly sensitive products | HSL suitable for pharmaceutical PVC |
PVC / PVdC | Higher moisture and oxygen barrier than uncoated PVC depending on PVdC construction | HSL validated against the exposed sealing surface |
High-Barrier PCTFE / Aclar Structure | Used where substantially improved moisture protection is required | Lidding chemistry must match the actual laminate sealing surface |
Cold-Form Alu-Alu | Very high barrier blister base using an aluminum-containing cold-form laminate | HSL selected for the polymer sealing layer of the cold-form laminate |
For highly moisture-sensitive formulations, stability data should determine whether conventional PVC blister, PVdC-coated film, high-barrier polymer laminate or cold-form Alu-Alu is required.
The inner heat-seal lacquer creates the bond between the aluminum lidding foil and the blister forming web.
Lacquer chemistry should be selected for the specific sealing substrate rather than treated as universally interchangeable between PVC, PVdC-coated film and cold-form laminate.
The current product information lists a seal-strength reference of ≥7.5N/15mm to PVC/PVdC.
For procurement acceptance, this value should be linked to a specified forming web, seal temperature, pressure, dwell time, conditioning procedure and peel-test method.
A stable blister process requires a practical sealing window rather than one nominal temperature. The converter should establish a validated range of temperature, pressure, dwell time and machine speed that produces acceptable seal integrity.
The exterior side can be supplied with a print primer or protective lacquer suitable for compatible pharmaceutical printing and coding systems.
Printed lidding can carry product name, strength, batch information, expiry information, dosage instructions, logos, barcodes and other approved artwork according to the customer's packaging design.
Ink, primer and protective lacquer should remain compatible with sealing temperatures and should be evaluated for adhesion, rub resistance, legibility and chemical suitability.
Where machine-readable barcodes, data codes or variable information are required, print contrast and readability should be validated using the intended printing and inspection system.
Pinhole control is important for pharmaceutical lidding because defects in the aluminum layer can reduce local barrier performance.
No universal zero-pinhole guarantee should be inferred solely from 20μm or 25μm foil thickness. Buyers should define an applicable inspection method, detection capability, sampling plan and acceptable defect limit.
Where online optical inspection is part of the manufacturing process, its detection threshold and rejection criteria should be included in the supplier quality agreement when required.
Coating and printing processes require controlled drying and curing so residual solvents remain within the limits established for the applicable pharmaceutical packaging specification.
A zero-residual-solvent assumption should not replace analytical testing. Where residual solvent is critical, buyers should specify the analytes, test method and maximum acceptance limits.
High-temperature and high-humidity distribution environments increase the importance of package barrier, seal integrity and stability testing for moisture-sensitive formulations.
The lidding foil alone should not be described as guaranteeing successful stability results in a specific climatic zone. Stability performance should be demonstrated using the actual dosage form and complete commercial package.
Where a product is intended for humid markets, the customer should provide the relevant stability program and required package-barrier target so the appropriate forming web and lidding system can be selected.
8011-H18 lidding foil can be used for compatible hard-gelatin capsule blisters. Foil thickness and push-through force should be selected so the lidding opens without unacceptable capsule deformation.
HPMC capsule formulations can also require controlled moisture exposure. Final package selection should be based on the capsule supplier's storage recommendations and stability data for the encapsulated formulation.
For capsules containing hygroscopic powders, pellets or granules, the complete blister barrier should be selected to control environmental moisture exposure throughout the intended shelf life.
Capsules used with dry-powder inhalation systems can have particularly strict moisture requirements. Packaging material should only be selected after the formulation, capsule and device requirements have been reviewed as a complete system.
Soft capsules can require different cavity, opening-force and barrier considerations from hard capsules. Standard push-through foil should therefore be evaluated carefully before it is specified for a softgel product.
Packaging Direction | General Use | Moisture-Sensitive Product Consideration |
|---|---|---|
PVC + Aluminum Lidding | Conventional thermoformed blister | Barrier may need review for highly moisture-sensitive formulations |
PVC/PVdC + Aluminum Lidding | Higher-barrier thermoform blister | PVdC coat weight and complete cavity barrier should match stability requirements |
PCTFE-Based Blister + Aluminum Lidding | High-moisture-barrier thermoform solution | Consider for products requiring higher moisture protection while retaining thermoforming |
Cold-Form Alu-Alu + Aluminum Lidding | Very high barrier blister construction | Consider where stability data require stronger protection from moisture, oxygen or light |
Stable packaging-line performance depends on foil gauge, slit width, winding quality, roll hardness, edge condition, coating uniformity and the compatibility of the HSL with the blister web.
Finished roll width should match the blister machine and web layout. Width tolerance, edge burr and telescoping requirements can be agreed according to line speed.
Core ID, maximum roll OD, roll weight and winding direction should be specified so the foil is compatible with the customer's unwind and web-handling system.
Where splices are permitted, splice count, marking and configuration should be defined in the purchase specification to reduce unexpected line interruptions.
The current product information references Class 100,000 controlled-room processing for coating, slitting and packaging operations.
Where a controlled manufacturing environment is required, buyers should request current facility-classification information, applicable process scope, environmental-monitoring procedures and supporting quality documentation.
Controlled-room processing supports contamination management but should not be described as guaranteeing sterility of the finished pharmaceutical package.
ISO 15378 addresses quality-management and Good Manufacturing Practice requirements for organizations manufacturing primary packaging materials for medicinal products.
Where ISO 15378 certification is required, buyers should request a current certificate showing the manufacturing site, certification body, validity period and scope relevant to the supplied packaging material.
Where a Drug Master File reference or supporting documentation is required for a regulatory submission, the current status and applicability to the exact foil, coating system and manufacturing site should be confirmed during supplier qualification.
For Saudi Arabia or other destination markets, buyers should identify the exact regulatory and submission documents required by their pharmaceutical product registration and packaging qualification process.
Where SASO-related documentation is requested by the customer or destination-market process, the applicable standard or conformity requirement should be identified specifically rather than assumed from the product description.
Pharmaceutical packaging materials should be supplied with appropriate batch identification so aluminum, lacquer, primer, coating and production information can be traced according to the agreed quality system.
After a packaging material has been qualified, changes to aluminum gauge, heat-seal lacquer, primer, coating weight, production location or other critical attributes should be managed according to the agreed supplier change-control process.
Inspection Item | What to Confirm |
|---|---|
Alloy and Temper | 8011-H18 and applicable incoming-material specification |
Foil Thickness | 20μm or 25μm nominal gauge and agreed tolerance |
WVTR | Required value, method, temperature and RH |
Pinhole Inspection | Inspection method, detection threshold and acceptance level |
Heat-Seal Lacquer | Coat weight, chemistry and compatible forming web |
Seal Strength | Forming web, sealing conditions, peel direction and minimum result |
Print Primer | Primer coat weight, ink compatibility and adhesion requirements |
Residual Solvent | Specified analytes, method and acceptance limits where required |
Slit Edge | Burr, edge damage and width tolerance |
Roll Quality | Winding, telescoping, core, roll OD and splice requirements |
Surface Appearance | Scratches, wrinkles, coating defects, contamination and printing defects |
Finished pharmaceutical foil rolls should be protected from moisture, dust, mechanical damage and contamination during storage and transportation.
Packaging can include inner protective wrapping, roll-end protection, sealed outer packaging, cartons and palletization according to roll dimensions and customer requirements.
Storage temperature, humidity, shelf life and acclimatization requirements should follow the approved lacquer, primer, printing and pharmaceutical packaging specification for the supplied construction.
To receive an accurate pharmaceutical lidding foil proposal, please provide as much of the following information as possible:
Dosage form: hard gelatin capsule, HPMC capsule, DPI capsule or other product
Formulation moisture sensitivity or hygroscopicity information
Required 8011-H18 specification
Foil thickness: 20μm, 25μm or other qualified gauge
Gauge tolerance requirement
PVC, PVC/PVdC, PCTFE-based or cold-form blister base
Required heat-seal lacquer chemistry or reference
Required HSL coating weight
Minimum seal strength
Seal-strength test method
Sealing temperature
Sealing pressure and dwell time
Machine speed
Required WVTR and test conditions
Pinhole acceptance requirement
Print-primer requirement
Printing method and ink system
Number of print colors
Barcode, data-code or artwork requirements
Residual-solvent requirements
Finished roll width and tolerance
Core inner diameter
Maximum roll outside diameter
Maximum or preferred roll weight
Winding direction and coated-side orientation
Splice requirements
Hot/humid stability-market requirements, if applicable
Required ISO 15378 certificate or quality-system documentation
Required DMF or destination-market regulatory documents
Required clean-room or environmental-control documentation
Required MTC, coating report and Certificate of Analysis
Order quantity
Destination country or delivery port
Send Your Capsule Blister Foil Specifications
H18 provides the hard-temper rupture behavior commonly required for push-through pharmaceutical blister lidding while maintaining stability during printing, slitting, sealing and handling.
Capsule shells and hygroscopic formulations can exchange moisture with the environment or with each other. Excess moisture or moisture loss can affect capsule flexibility, brittleness and product stability, so package selection should follow actual stability data.
Neither gauge is universally better. A 25μm foil generally requires greater push-through force, while 20μm can provide easier rupture. The final choice should be validated with the actual capsule and blister cavity.
Heat-seal strength is primarily controlled by the heat-seal lacquer, forming web and sealing conditions. Foil thickness mainly affects mechanical and push-through behavior.
The current product information publishes a WVTR reference below 0.01g/m²·24h. The applicable test method, temperature, relative humidity and sample construction should be confirmed when this is a purchase requirement.
The aluminum lidding provides extremely high barrier through the intact foil, but total blister moisture protection also depends on the forming web, seals, edges, cavity geometry and package integrity.
It depends on the formulation and stability requirements. Highly moisture-sensitive products may require a higher-barrier forming web such as PVC/PVdC, PCTFE-based laminate or cold-form Alu-Alu.
Suitable pharmaceutical HSL systems can be configured for PVC/PVdC. The exact forming film and exposed sealing surface should be confirmed before production.
The current product information publishes ≥7.5N/15mm to PVC/PVdC as a reference. The forming web and test conditions must be defined when using this as an acceptance criterion.
Yes. A compatible print primer can support pharmaceutical text, branding, batch information, expiry information and machine-readable codes according to the approved printing system.
A universal zero-pinhole guarantee should not be assumed solely from foil gauge. Buyers should define the required inspection method, detection threshold and acceptance level.
No packaging component alone guarantees pharmaceutical stability. Stability must be demonstrated using the actual formulation and complete commercial package under the required storage conditions.
ISO 15378 is a quality-management and GMP standard for organizations manufacturing primary packaging materials for medicinal products. The current certificate and manufacturing scope should be verified for the supplier site.
Yes, suitable lidding foil can be used with compatible cold-form blister systems when the HSL is designed for the polymer sealing surface of the cold-form laminate.
Not automatically. Child-resistant or senior-friendly pharmaceutical packaging requires a specialized complete package construction and applicable performance testing.
It can be evaluated for selected soft capsule products, but push-through force, capsule strength, cavity geometry and moisture requirements should be validated specifically for the product.
It can be considered for suitable DPI capsule blister systems, but moisture requirements should be defined from the capsule, dry-powder formulation and inhalation-device qualification program.
Yes. Finished roll width can be slit according to the blister-machine layout. Width tolerance, edge condition, core ID, roll OD and winding direction should be specified.
Sample availability can be confirmed according to foil thickness, HSL, forming web, roll width and printing requirements. Packaging-line and stability trials are recommended before commercial approval.
Depending on the market and quality system, buyers can request current ISO 15378 documentation, material certificates, coating specifications, Certificate of Analysis, DMF-related information and applicable destination-market documents.
Please provide capsule type, formulation sensitivity, forming web, foil gauge, width, HSL specification, seal conditions, WVTR requirement, pinhole limits, printing, roll dimensions, regulatory documentation, quantity and destination.
Products
Application
Quick links
Contact Us